The sale process for Veradigm, née Allscripts, has kicked off and indications of interest were collected last week, Axios has confirmed. The electronic medical record data company presents a profitable, digestible asset to private equity buyers looking for a data foothold. Bids have come in above the company’s $9.50 share price, one source tells Axios. Veradigm’s market cap sits at about $1 billion. Thoma Bravo, which took EHR software company NextGen private for $1.8 billion last year, is among the private equity firms looking, Ion Analytics first reported.
Read the full article: Private Equity Firms Circle EMR Data Company Veradigm //
Source: https://www.axios.com/pro/health-tech-deals/2024/08/14/private-equity-emr-data-veradigm-take-private